SCHEMBL10140476

SCHEMBL10140476

CC(=O)c1cc(C)cc(C(=O)N2CCCC2c2cccs2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.57
RAB9A P51151 1/20 0.57
POLB P06746 1/20 0.52
HSD17B10 Q99714 1/20 0.45
KDM4E B2RXH2 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GRM5 P41594 2/20 0.43
HCRTR1 O43613 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
PKM P14618 1/20 0.40
KIF11 P52732 1/20 0.40
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166804 0.92 NPC1 (0.56) NPC1RAB9APOLBHSD17B10KDM4E
SCHEMBL167074 0.89 NPC1 (0.56) NPC1RAB9APOLBHSD17B10GRM5
SCHEMBL256556 0.82 RIPK1 (0.53)
SCHEMBL166512 0.81 POLB (0.57) NPC1RAB9APOLBHSD17B10GRM5
SCHEMBL164861 0.80 POLB (0.53) NPC1RAB9APOLBHSD17B10MEN1
SCHEMBL166110 0.76 POLB (0.47) NPC1RAB9APOLBHSD17B10KDM4E
SCHEMBL715644 0.75 POLB (0.50) NPC1RAB9APOLBHSD17B10KDM4E
SCHEMBL167476 0.74 NPC1 (0.45) NPC1RAB9APOLBHSD17B10KDM4E
SCHEMBL716612 0.73 NPC1 (0.46) NPC1RAB9APOLBHSD17B10KDM4E
SCHEMBL166963 0.73 RIPK1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed